These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1551096)
1. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Boone CW; Kelloff GJ; Steele VE Cancer Res; 1992 Apr; 52(7):1651-9. PubMed ID: 1551096 [TBL] [Abstract][Full Text] [Related]
2. The natural history of intraepithelial neoplasia: relevance to the search for intermediate endpoint biomarkers. Boone CW; Kelloff GJ; Steele VE J Cell Biochem Suppl; 1992; 16G():23-6. PubMed ID: 1469901 [TBL] [Abstract][Full Text] [Related]
3. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents. Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ J Cell Biochem Suppl; 1997; 28-29():1-20. PubMed ID: 9589346 [TBL] [Abstract][Full Text] [Related]
4. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis. Boone CW; Kelloff GJ Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626 [TBL] [Abstract][Full Text] [Related]
5. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659 [TBL] [Abstract][Full Text] [Related]
6. Karyometry in the early detection and chemoprevention of intraepithelial lesions. Ranger-Moore J; Alberts DS; Montironi R; Garcia F; Davis J; Frank D; Brewer M; Mariuzzi GM; Bartels HG; Bartels PH Eur J Cancer; 2005 Sep; 41(13):1875-88. PubMed ID: 16087328 [TBL] [Abstract][Full Text] [Related]
7. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis. DiGiovanni J; Rho O; Xian W; Beltràn L Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243 [TBL] [Abstract][Full Text] [Related]
8. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331 [TBL] [Abstract][Full Text] [Related]
9. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. Boone CW; Kelloff GJ J Cell Biochem Suppl; 1994; 19():10-22. PubMed ID: 7823580 [TBL] [Abstract][Full Text] [Related]
10. Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation. Das RK; Hossain SK; Bhattacharya S Cancer Lett; 2005 Dec; 230(1):90-101. PubMed ID: 16253765 [TBL] [Abstract][Full Text] [Related]
11. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971 [TBL] [Abstract][Full Text] [Related]
12. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion. Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245 [TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of sarcophine-diol on skin tumor development in CD-1 mice. Zhang X; Kundoor V; Khalifa S; Zeman D; Fahmy H; Dwivedi C Cancer Lett; 2007 Aug; 253(1):53-9. PubMed ID: 17321042 [TBL] [Abstract][Full Text] [Related]
14. In vivo long-term effects of retinoic acid exposure in utero on induced tumours in adult mouse skin. García-Fernández RA; Pérez-Martínez C; García-Iglesias MJ Vet Dermatol; 2014 Dec; 25(6):538-46, e93-4. PubMed ID: 25041412 [TBL] [Abstract][Full Text] [Related]
15. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
16. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Meeran SM; Vaid M; Punathil T; Katiyar SK Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151 [TBL] [Abstract][Full Text] [Related]
17. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials. Bostwick DG; Aquilina JW J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613 [TBL] [Abstract][Full Text] [Related]
18. The premalignant nature of mouse skin papillomas: histopathologic, cytogenetic, and biochemical evidence. Aldaz CM; Conti CJ Carcinog Compr Surv; 1989; 11():227-42. PubMed ID: 2465820 [No Abstract] [Full Text] [Related]
19. Sequential studies of skin tumorigenesis in phosphoglycerate kinase mosaic mice: effect of resumption of promotion on regressed papillomas. Reddy AL; Caldwell M; Fialkow PJ Cancer Res; 1987 Apr; 47(7):1947-51. PubMed ID: 3102053 [TBL] [Abstract][Full Text] [Related]